Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Hexaxim vs Infanrix Hexa in Peruvian Infants
NCT00831753Phase 3Completed
- Sponsor
- Sanofi
- Start
- May 2008
- Primary completion
- May 2009
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of hexaxim in diphtheria, Tetanus, pertussis, hepatitis B (HBV), poliomyelitis, sponsored by Sanofi. Started May 2008; status: completed.
02
Drugs
hexaxim
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)poliomyelitis
Beyond the preview
Go deeper on NCT00831753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00831753.